ADIL Adial Pharmaceuticals, Inc.

NASDAQ
$6.22

Adial Pharmaceuticals, Inc. (ADIL) SEC Filings

Everything ADIL has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

16 filings
Date Form Filing
8-K DELISTING
8-K EARNINGS_RELEASE
8-K ACQUISITION_DISPOSITION
8-K CAPITAL_RAISE
8-K EXECUTIVE_CHANGE
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.